Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness (PDR-Study)
Phase: PHASE1 | Sponsor: University Hospital, Basel, Switzerland | Compound: Psilocybin
- Status
- recruiting
- Institution
- University Hospital, Basel, Switzerland
- Start date
- 2025-04-21
- End date
- 2026-08-01
- Registry ID
- NCT06796361
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.